Prahlad Singh

President and Chief Executive Officer at REVVITY

Board

Since December 30, 2019

Age

60 years

Education

Holds a doctoral degree in chemistry from the University of Missouri-Columbia and an MBA from Northeastern University.

Tenure

Joined RVTY in May 2014 as President of the Diagnostics business, served as Senior Vice President and Executive Vice President, then as President and COO beginning January 2019 before becoming President and CEO on December 30, 2019.

Also at REVVITY

Anita Gonzales

Vice President and Controller

DRT

Daniel R. Tereau

Senior Vice President, Strategy and Business Development

JSG

Joel S. Goldberg

Senior Vice President, Administration, General Counsel, and Secretary

About

Prahlad Singh is the 60-year-old President and Chief Executive Officer of Revvity, having assumed the role on December 30, 2019.

He began his tenure at Revvity in May 2014 as the President of the Diagnostics business. Over the years, he has advanced through significant leadership roles, including promotions to Senior Vice President in September 2016, Executive Vice President in March 2018, and later to President and Chief Operating Officer in January 2019 before his current appointment.

Academically, he holds a doctoral degree in chemistry from the University of Missouri-Columbia and an MBA from Northeastern University. Prior to joining Revvity, he built an impressive career by holding senior executive roles in companies such as GE Healthcare, Philips Healthcare, DuPont Pharmaceuticals, and Bristol-Myers Squibb Medical Imaging, contributing to strategic initiatives and operational excellence in the healthcare sector.

$RVTY Performance Under Prahlad Singh

Past Roles

Organization	Role	Date Range	Details
Revvity (RVTY)	President and Chief Operating Officer	Jan 2019 - Dec 2019	Served prior to being elected CEO on Dec 30, 2019
Revvity (RVTY)	Executive Vice President	Mar 2018 - Jan 2019	Promoted from Senior VP
Revvity (RVTY)	Senior Vice President	Sep 2016 - Mar 2018
Revvity (RVTY)	President of the Diagnostics Business	May 2014 - Sep 2016	Joined RVTY in May 2014 leading the Diagnostics business
GE Healthcare	General Manager, Women’s Health Business	2012 - 2014	Oversaw mammography and bone densitometry businesses; held senior executive roles in strategy, business development and M&A
Philips Healthcare	Senior Executive (Strategy, Business Development & M&A)	N/A
DuPont Pharmaceuticals	Leadership Roles	N/A	Held roles of increasing responsibility
Bristol-Myers Squibb Medical Imaging	Regional Manager (Asia Pacific & Middle East)	N/A	Managed the Asia Pacific and Middle East region

External Roles

Organization	Role	Date Range	Details
Amphenol Corporation	Board Member	N/A	Publicly traded
Analytical, Life Sciences & Diagnostics Association (ALDA)	Board Member	N/A
Massachusetts General Hospital	Member, President’s Council	N/A

Fixed Compensation

Data from FY 2023

Component Name	Amount ($)	Payment Schedule	Additional Details
Base Salary	1,086,539	N/A	Fixed yearly salary
401(k) Company Match	15,250	N/A	Included in All Other Compensation
Executive Health Program	2,227	N/A	Included in All Other Compensation
Life Insurance Premiums	15,000	N/A	Included in All Other Compensation

Performance Compensation

Data from FY 2023

Performance Metrics

Metric	Weight (%)	Threshold	Target	Maximum	Actual Result
Non-COVID Organic Revenue	40	7.0%	9.0%	12.0%	2.0% (0% achievement)
Adjusted EPS	40	$4.85	$5.15	$5.55	$4.78 (0% achievement)
Free Cash Flow Conversion	20	70%	80-85%	100%	77% (85% achievement)

Award Breakdown

Target Award Opportunity: $1,485,000 (135% of base salary)
Approved Award: $315,563 (21% of the target award)
Evaluation Period: Full fiscal year 2023
Vesting Schedule: Not applicable – cash incentive
Grant Date / Stock Price: Not applicable as it is not an equity-based award